Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · Real-Time Price · USD

0.6256

-0.0341 (-5.17%)

At close: Jul 25, 2025, 4:00 PM

0.6165

-0.0091 (-1.45%)

After-hours: Jul 25, 2025, 7:31 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Allogeneic Cell Therapies	2.24M	Log In
Allogeneic Cell Therapies Growth	-57.01%	Log In

Revenue by Geography

Fiscal year is January - December.